Response to Comments: Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)

This article is a response-to-comments document for the Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT) Local Coverage Determination L40048 and does not itself state clinical coverage criteria. The LCD's comment period occurred 2025-02-13 to 2025-03-29; the notice period begins 2025-09-11 and the LCD becomes effective 2025-10-26. Refer to LCD L40048 for the full coverage, limitation, and documentation requirements.

"This article documents responses to comments received during the open comment period for LCD L40048 Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)."

Sign up to see full coverage criteria, indications, and limitations.